Home > Insider Trading > Filing (0001387131-19-009327)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1430306	Tonix Pharmaceuticals Holding Corp.	TNXP	Pharmaceutical Preparations (2834)	261434750

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1563420	Seth Lederman	C/O Tonix Pharmaceuticals Holding Corp 509 Madison Avenue, Suite 1608 New York NY 10022	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	Acquisiton	2019-12-03	20,000	$1.16	23,267	No	4	P	Indirect	By 401(k) plan

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By 401(k) plan

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	459	Indirect	By IRA Account
Common Stock, $0.001 Par Value	177	Direct
Common Stock, $0.001 Par Value	31	Indirect	By spouse
Common Stock, $0.001 Par Value	30	Indirect	By Leder Laboratories, Inc.
Common Stock, $0.001 Par Value	30	Indirect	By Starling Pharmaceuticals, Inc.
Common Stock, $0.001 Par Value	205	Indirect	By Lederman & Co., LLC
Common Stock, $0.001 Par Value	33	Indirect	By L&L Technologies, LLC
Common Stock, $0.001 Par Value	59	Indirect	By Targent Pharmaceuticals, LLC

Footnotes

The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $1.15 to $1.16, inclusive. The reporting person undertakes to provide to Tonix Pharmaceuticals Holding Corp., any security holder of Tonix Pharmaceuticals Holding Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.